KRT19 and benign thyroid gland neoplasm: At present, there are some markers for the differential diagnosis of PTC and benign thyroid tumor with papillary hyperplasia, such as CK19/Galectin-3/HBME1, but they are limited in clinical use because of their relative lower sensitivity and specificity.